A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection
Clinical trial NCT06801223 · RECRUITING
Trial details
- NCT number
- NCT06801223
- Sponsor
- Innoviva Specialty Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-30
- Primary completion
- 2028-05-05
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.